2,508
Views
13
CrossRef citations to date
0
Altmetric
Laboratory Study

Yishen capsule promotes podocyte autophagy through regulating SIRT1/NF-κB signaling pathway to improve diabetic nephropathy

, , , , , , , , , , , & show all
Pages 128-140 | Received 03 Aug 2020, Accepted 16 Dec 2020, Published online: 11 Jan 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Ziyuan Zhang, Yaling Hu, Wenyuan Liu, Xiaodong Zhang, Ruihua Wang, Hui Li, Dalin Sun & Jingai Fang. (2022) Yishen Capsule Alleviated Symptoms of Diabetic Nephropathy via NOD-like Receptor Signaling Pathway. Diabetes, Metabolic Syndrome and Obesity 15, pages 2183-2195.
Read now
Yaling Hu, Shuang Liu, Wenyuan Liu, Ziyuan Zhang, Yuxiang Liu, Sufen Li, Dalin Sun, Guang Zhang & Jingai Fang. (2022) Potential Molecular Mechanism of Yishen Capsule in the Treatment of Diabetic Nephropathy Based on Network Pharmacology and Molecular Docking. Diabetes, Metabolic Syndrome and Obesity 15, pages 943-962.
Read now
Xiaolong Li, Yujie Wen, Liyuan Sheng, Rui Guo, Yanli Zhang & Longquan Shao. (2022) Icariin activates autophagy to trigger TGFβ1 upregulation and promote angiogenesis in EA.hy926 human vascular endothelial cells. Bioengineered 13:1, pages 164-177.
Read now

Articles from other publishers (10)

Bo Li, Xu Zhao, Wanrun Xie, Zhenzhen Hong & Yi Zhang. (2023) Integrative analyses of biomarkers and pathways for diabetic nephropathy. Frontiers in Genetics 14.
Crossref
Yu-Peng Han, Li-Juan Liu, Jia-Lin Yan, Meng-Yuan Chen, Xiang-Fei Meng, Xin-Ru Zhou & Ling-Bo Qian. (2023) Autophagy and its therapeutic potential in diabetic nephropathy. Frontiers in Endocrinology 14.
Crossref
Peng Liu, Wenhui Zhu, Yang Wang, Guijie Ma, Hailing Zhao & Ping Li. (2023) Chinese herbal medicine and its active compounds in attenuating renal injury via regulating autophagy in diabetic kidney disease. Frontiers in Endocrinology 14.
Crossref
Ying Huang, Xueqin Gao, Yang An, Ping Zeng, Changming Chen, Wukai Ma & Xueming Yao. (2023) Inhibitory Effect of Jinwujiangu Prescription on Peripheral Blood Osteoclasts in Patients with Rheumatoid Arthritis and the Relevant Molecular Mechanism. Mediators of Inflammation 2023, pages 1-17.
Crossref
Pei-Pei Su, Dong-Wei Liu, Si-Jie Zhou, Hang Chen, Xian-Ming Wu & Zhang-Suo Liu. (2022) Down-regulation of Risa improves podocyte injury by enhancing autophagy in diabetic nephropathy. Military Medical Research 9:1.
Crossref
Jingai Fang, Chendan Wang, Jie Zheng & Yuxiang Liu. (2022) Network pharmacology study of Yishen capsules in the treatment of diabetic nephropathy. PLOS ONE 17:9, pages e0273498.
Crossref
Xiao-Juan Liu, Xiang-Ka Hu, He Yang, Liu-Ming Gui, Zeng-Xiaorui Cai, Mu-Shuang Qi & Chun-Mei Dai. (2022) A Review of Traditional Chinese Medicine on Treatment of Diabetic Nephropathy and the Involved Mechanisms. The American Journal of Chinese Medicine 50:07, pages 1739-1779.
Crossref
Shilin Liu, Andong Li, Bin Jiang, Jia Mi, Hongmei Nan, Pengjie Bao & Zheng Nan. (2022) Comparison of efficacy and safety of traditional Chinese patent medicines for diabetic nephropathy. Medicine 101:19, pages e29152.
Crossref
Xiaomei Yang, Xuke Han, Qing Wen, Xianliang Qiu, Huan Deng & Qiu Chen. (2021) Protective Effect of Keluoxin against Diabetic Nephropathy in Type 2 Diabetic Mellitus Models. Evidence-Based Complementary and Alternative Medicine 2021, pages 1-10.
Crossref
Seyed Hossein Shahcheraghi, Alaa A.A. Aljabali, Mazhar S. Al Zoubi, Vijay Mishra, Nitin B. Charbe, Yusuf A. Haggag, Garima Shrivastava, Abdulmajeed G. Almutary, Abdullah M. Alnuqaydan, Debmalya Barh, Kamal Dua, Dinesh K. Chellappan, Gaurav Gupta, Marzieh Lotfi, Ángel Serrano-Aroca, Bojlul Bahar, Yogendra Kumar Mishra, Kazuo Takayama, Pritam Kumar Panda, Hamid A. Bakshi & Murtaza M. Tambuwala. (2021) Overview of key molecular and pharmacological targets for diabetes and associated diseases. Life Sciences 278, pages 119632.
Crossref